Latest News

Severe Emphysema Benefits From Zephyr® Endobronchial Valve Treatment

COPD Risk From Secondhand Smoke May Be Linked With Lung Volume Variations

Triple Therapy Recommended for COPD With Infrequent Exacerbations

Age-Obesity Interaction in Pulmonary Arterial Hypertension

Intranasal Epinephrine for Anaphyalxis Looks Promising in Early Study

Ivacaftor Decreases Mortality, Hospitalization in Cystic Fibrosis

Recombinant Human Pentraxin 2 Slowed Lung Function Decline in IPF

PAH in Systemic Sclerosis Increases Risk for Early Mortality

CTEPH Increases Risk for Sleep Disordered Breathing

Various Perinatal Risks Associated With Maternal Asthma Diagnosis

more »

Latest Features

Practice Management A Few Bad Apples: Managing Malpractice Claims

A Few Bad Apples: Managing Malpractice Claims

By

Ranking or otherwise gauging physician quality isn't just a way to assign bragging rights — performance metrics can be used to set reimbursement levels, tailor insurance, and identify physicians who are falling behind.

Pulmonary Arterial Hypertension-PAH Biomarkers of PAH Risk in Patients With SLE

Biomarkers of PAH Risk in Patients With SLE

By June 09, 2017

Meta-analysis supports anti-RNP and anti-Sm antibodies as serological biomarkers of PAH risk in patients with SLE.

COPD Triple Therapy Superior to Long-acting Muscarinic Antagonist for COPD

Triple Therapy Superior to Long-acting Muscarinic Antagonist for COPD

By May 22, 2017

The TRINITY study reports the significant benefits to extafine triple therapy taken in a single inhaler compared with tiotropium in chronic obstructive pulmonary disease.

Drug Lookup

Search our drug information database which contains an extensive list of pulmonology drugs.

Browse drugs by:

Brand Generic Disease
Powered By :

Sign Up for Free e-newsletters